Riccardo Canevari
CEO,
Radiopharm Theranostics
United States
CEO since 2021, previously Chief Commercial Officer at Novartis, Advance Accelerator Applications (AAA)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}